Adenosine deaminase potentiates the generation of effector, memory, and regulatory CD4+ T cells

Journal of Leukocyte Biology

Volumn 89, Issue 1, 2011, Pages 127-136

  Martinez Navio, José M ^a   Casanova, Víctor ^a   Pacheco, Rodrigo ^c,d   Naval Macabuhay, Isaac ^a   Climent, Núria ^a   Garcia, Felipe ^a,b   Gatell, José M ^a,b   Mallol, Josefa ^a   Gallart, Teresa ^a   Lluis, Carme ^a   Franco, Rafael ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c Fundacion Ciencia para la Vida   (Chile)

^d UNIVERSIDAD SAN SEBASTIÁN   (Chile)

Author keywords

CD26; CD45RA CD45RO; Dendritic cells; Foxp3; T cell activation; Th1

Indexed keywords

ADENOSINE DEAMINASE; GAMMA INTERFERON; INTERLEUKIN 6; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MALE; MEMORY T LYMPHOCYTE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ADENOSINE DEAMINASE; ADULT; ANTIGENS, CD4; ANTIGENS, CD45; CELL PROLIFERATION; COCULTURE TECHNIQUES; DENDRITIC CELLS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; INTERLEUKIN-6; MALE; MIDDLE AGED; PHENOTYPE; T-LYMPHOCYTES, REGULATORY; TUMOR NECROSIS FACTOR-ALPHA;

ERAGROSTIS TEF;

EID: 79251561879     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1009696     Document Type: Article

References (55)

1. DiPaolo, R. J., Brinster, C., Davidson, T. S., Andersson, J., Glass, D., Shevach, E. M. (2007) Autoantigen-specific TGFβ-induced Foxp3+ regulatory T cells prevent autoimmunity by inhibiting dendritic cells from activating autoreactive T cells. J. Immunol. 179, 4685-4693.
2. Vandenbark, A. A., Offner, H. (2008) Critical evaluation of regulatory T cells in autoimmunity: are the most potent regulatory specificities being ignored? Immunology 125, 1-13.
3. Abbal, C., Jourdan, P., Hori, T., Bousquet, J., Yssel, H., Pene, J. (1999) TCR-mediated activation of allergen-specific CD45RO(+) memory T lymphocytes results in down-regulation of cell-surface CXCR4 expression and a strongly reduced capacity to migrate in response to stromal cell-derived factor-1. Int. Immunol. 11, 1451-1462.
4. Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M., Selby, W., Alexander, S. I., Nanan, R., Kelleher, A., Fazekas de St Groth, B. (2006) Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J. Exp. Med. 203, 1693-1700.
5. Badovinac, V. P., Harty, J. T. (2006) Programming, demarcating, and manipulating CD8+ T-cell memory. Immunol. Rev. 211, 67-80.
6. Farber, D. L. (1998) Differential TCR signaling and the generation of memory T cells. J. Immunol. 160, 535-539.
7. Franco, R., Valenzuela, A., Lluis, C., Blanco, J. (1998) Enzymatic and extraenzymatic role of ecto-adenosine deaminase in lymphocytes. Immunol. Rev. 161, 27-42.
8. Franco, R., Pacheco, R., Gatell, J. M., Gallart, T., Lluis, C. (2007) Enzymatic and extraenzymatic role of adenosine deaminase 1 in T-cell-dendritic cell contacts and in alterations of the immune function. Crit. Rev. Immunol. 27, 495-509.
9. Pacheco, R., Lluis, C., Franco, R. (2005) Role of CD26-adenosine deaminase interaction in the T cell-mediated immunity. Inmunología 24, 235-245 (http://revista.immunologia.org/Upload/Articles/6/5/658.pdf).
10. Hershfield, M. S. (2005) New insights into adenosine-receptor-mediated immunosuppression and the role of adenosine in causing the immunodeficiency associated with adenosine deaminase deficiency. Eur. J. Immunol. 35, 25-30.
11. Ohta, A., Sitkovsky, M. (2001) Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414, 916-920.
12. Huang, S., Apasov, S., Koshiba, M., Sitkovsky, M. (1997) Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 90, 1600-1610. (Pubitemid 27355433)
13. Gessi, S., Varani, K., Merighi, S., Ongini, E., Borea, P. A. (2000) A(2A) adenosine receptors in human peripheral blood cells. Br. J. Pharmacol. 129, 2-11.
14. Pacheco, R., Martinez-Navio, J. M., Lejeune, M., Climent, N., Oliva, H., Gatell, J. M., Gallart, T., Mallol, J., Lluis, C., Franco, R. (2005) CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse. Proc. Natl. Acad. Sci. USA 102, 9583-9588.
15. Panther, E., Corinti, S., Idzko, M., Herouy, Y., Napp, M., la Sala, A., Girolomoni, G., Norgauer, J. (2003) Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells. Blood 101, 3985-3990.
16. Panther, E., Idzko, M., Herouy, Y., Rheinen, H., Gebicke-Haerter, P. J., Mrowietz, U., Dichmann, S., Norgauer, J. (2001) Expression and function of adenosine receptors in human dendritic cells. FASEB J. 15, 1963-1970.
17. Fossetta, J., Jackson, J., Deno, G., Fan, X., Du, X. K., Bober, L., Soude-Bermejo, A., de Bouteiller, O., Caux, C., Lunn, C., Lundell, D., Palmer, R. K. (2003) Pharmacological analysis of calcium responses mediated by the human A3 adenosine receptor in monocyte-derived dendritic cells and recombinant cells. Mol. Pharmacol. 63, 342-350.
18. Hofer, S., Ivarsson, L., Stoitzner, P., Auffinger, M., Rainer, C., Romani, N., Heufler, C. (2003) Adenosine slows migration of dendritic cells but does not affect other aspects of dendritic cell maturation. J. Invest. Dermatol. 121, 300-307. (Pubitemid 36969904)
19. Schnurr, M., Toy, T., Shin, A., Hartmann, G., Rothenfusser, S., Soellner, J., Davis, I. D., Cebon, J., Maraskovsky, E. (2004) Role of adenosine receptors in regulating chemotaxis and cytokine production of plasmacytoid dendritic cells. Blood 103, 1391-1397.
20. Aandahl, E. M., Moretto, W. J., Haslett, P. A., Vang, T., Bryn, T., Tasken, K., Nixon, D. F. (2002) Inhibition of antigen-specific T cell proliferation and cytokine production by protein kinase A type I. J. Immunol. 169, 802-808.
21. Cone, R. E., Cochrane, R., Lingenheld, E. G., Clark, R. B. (1996) Elevation of intracellular cyclic AMP induces an anergic-like state in Th1 clones. Cell. Immunol. 173, 246-251.
22. Dong, R. P., Kameoka, J., Hegen, M., Tanaka, T., Xu, Y., Schlossman, S. F., Morimoto, C. (1996) Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response. J. Immunol. 156, 1349-1355.
23. Hashikawa, T., Hooker, S. W., Maj, J. G., Knott-Craig, C. J., Takedachi, M., Murakami, S., Thompson, L. F. (2004) Regulation of adenosine receptor engagement by ecto-adenosine deaminase. FASEB J. 18, 131-133.
24. Martinez-Navio, J. M., Climent, N., Pacheco, R., Garcia, F., Plana, M., Nomdedeu, M., Oliva, H., Rovira, C., Miralles, L., Gatell, J. M., Gallart, T., Mallol, J., Lluis, C., Franco, R. (2009) Immunological dysfunction in HIV-1-infected individuals by impairment of adenosine deaminase-induced co-stimulation of T-cell activation. Immunology 128, 393-404.
25. Climent, N., Martinez-Navio, J. M., Gil, C., Garcia, F., Rovira, C., Hurtado, C., Miralles, L., Gatell, J. M., Gallart, T., Mallol, J., Lluis, C., Franco, R. (2009) Adenosine deaminase enhances T-cell response elicited by dendritic cells loaded with inactivated HIV. Immunol. Cell Biol. 87, 634-639.
26. Ginés, S., Ciruela, F., Burgueno, J., Casado, V., Canela, E. I., Mallol, J., Lluis, C., Franco, R. (2001) Involvement of caveolin in ligand-induced recruitment and internalization of A(1) adenosine receptor and adenosine deaminase in an epithelial cell line. Mol. Pharmacol. 59, 1314-1323.
27. Franco, R., Canela, E. I., Bozal, J. (1986) Heterogeneous localization of some purine enzymes in subcellular fractions of rat brain and cerebellum. Neurochem. Res. 11, 423-435. (Pubitemid 16129128)
28. Ciruela, F., Saura, C., Canela, E. I., Mallol, J., Lluis, C., Franco, R. (1996) Adenosine deaminase affects ligand-induced signaling by interacting with cell surface adenosine receptors. FEBS Lett. 380, 219-223. (Pubitemid 26063938)
29. Bøyum, A. (1976) Isolation of lymphocytes, granulocytes and macrophages. Scand. J. Immunol. 5, 9-15.
30. Hirschhorn, R. (1995) Adenosine deaminase deficiency: molecular basis and recent developments. Clin. Immunol. Immunopathol. 76, S219-S227.
31. Resta, R., Thompson, L. F. (1997) SCID: the role of adenosine deaminase deficiency. Immunol. Today 18, 371-374. (Pubitemid 27315709)
32. Mirabet, M., Herrera, C., Cordero, O. J., Mallol, J., Lluis, C., Franco, R. (1999) Expression of A2B adenosine receptors in human lymphocytes: their role in T cell activation. J. Cell Sci. 112, 491-502.
33. Gessi, S., Varani, K., Merighi, S., Cattabriga, E., Pancaldi, C., Szabadkai, Y., Rizzuto, R., Klotz, K. N., Leung, E., Mac Lennan, S., Baraldi, P. G., Borea, P. A. (2005) Expression, pharmacological profile, and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells using a novel selective antagonist radioligand, [3H]MRE 2029-F20. Mol. Pharmacol. 67, 2137-2147.
34. Gessi, S., Varani, K., Merighi, S., Cattabriga, E., Avitabile, A., Gavioli, R., Fortini, C., Leung, E., Mac Lennan, S., Borea, P. A. (2004) Expression of A3 adenosine receptors in human lymphocytes: up-regulation in T cell activation. Mol. Pharmacol. 65, 711-719.
35. Csóka, B., Himer, L., Selmeczy, Z., Vizi, E. S., Pacher, P., Ledent, C., Deitch, E. A., Spolarics, Z., Nemeth, Z. H., Hasko, G. (2008) Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function. FASEB J. 22, 3491-3499.
36. Aran, J. M., Colomer, D., Matutes, E., Vives-Corrons, J. L., Franco, R. (1991) Presence of adenosine deaminase on the surface of mononuclear blood cells: immunochemical localization using light and electron microscopy. J. Histochem. Cytochem. 39, 1001-1008.
37. Martín, M., Aran, J. M., Colomer, D., Huguet, J., Centelles, J. J., Vives-Corrons, J. L., Franco, R. (1995) Surface adenosine deaminase. A novel B-cell marker in chronic lymphocytic leukemia. Hum. Immunol. 42, 265-273.
38. Kameoka, J., Tanaka, T., Nojima, Y., Schlossman, S. F., Morimoto, C. (1993) Direct association of adenosine deaminase with a T cell activation antigen, CD26. Science 261, 466-469.
39. Saura, C., Ciruela, F., Casado, V., Canela, E. I., Mallol, J., Lluis, C., Franco, R. (1996) Adenosine deaminase interacts with A1 adenosine receptors in pig brain cortical membranes. J. Neurochem. 66, 1675-1682.
40. Herrera, C., Casado, V., Ciruela, F., Schofield, P., Mallol, J., Lluis, C., Franco, R. (2001) Adenosine A2B receptors behave as an alternative anchoring protein for cell surface adenosine deaminase in lymphocytes and cultured cells. Mol. Pharmacol. 59, 127-134.
41. Gracia, E., Cortes, A., Meana, J. J., Garcia-Sevilla, J., Herhsfield, M. S., Canela, E. I., Mallol, J., Lluis, C., Franco, R., Casado, V. (2008) Human adenosine deaminase as an allosteric modulator of human A(1) adenosine receptor: abolishment of negative cooperativity for [H](R)-pia binding to the caudate nucleus. J. Neurochem. 107, 161-170.
42. Ishii, T., Ohnuma, K., Murakami, A., Takasawa, N., Kobayashi, S., Dang, N. H., Schlossman, S. F., Morimoto, C. (2001) CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO. Proc. Natl. Acad. Sci. USA 98, 12138-12143.
43. Kobayashi, S., Ohnuma, K., Uchiyama, M., Iino, K., Iwata, S., Dang, N. H., Morimoto, C. (2004) Association of CD26 with CD45RA outside lipid rafts attenuates cord blood T-cell activation. Blood 103, 1002-1010.
44. Deaglio, S., Dwyer, K. M., Gao, W., Friedman, D., Usheva, A., Erat, A., Chen, J. F., Enjyoji, K., Linden, J., Oukka, M., Kuchroo, V. K., Strom, T. B., Robson, S. C. (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J. Exp. Med. 204, 1257-1265.
45. Mandapathil, M., Hilldorfer, B., Szczepanski, M. J., Czystowska, M., Szajnik, M., Ren, J., Lang, S., Jackson, E. K., Gorelik, E., Whiteside, T. L. (2010) Generation and accumulation of immunosuppressive adenosine by human CD4+CD25highFOXP3+ regulatory T cells. J. Biol. Chem. 285, 7176-7186.
46. Vanham, G., Kestens, L., De Meester, I., Vingerhoets, J., Penne, G., Vanhoof, G., Scharpe, S., Heyligen, H., Bosmans, E., Ceuppens, J. L., et al. (1993) Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV-infected subjects. J. Acquir. Immune Defic. Syndr. 6, 749-757.
47. Blazquez, M. V., Madueno, J. A., Gonzalez, R., Jurado, R., Bachovchin, W. W., Pena, J., Munoz, E. (1992) Selective decrease of CD26 expression in T cells from HIV-1-infected individuals. J. Immunol. 149, 3073-3077.
48. De Paoli, P., Zanussi, S., Simonelli, C., Bortolin, M. T., D'Andrea, M., Crepaldi, C., Talamini, R., Comar, M., Giacca, M., Tirelli, U. (1997) Effects of subcutaneous interleukin-2 therapy on CD4 subsets and in vitro cytokine production in HIV+ subjects. J. Clin. Invest. 100, 2737-2743. (Pubitemid 28007541)
49. Valenzuela, A., Blanco, J., Callebaut, C., Jacotot, E., Lluis, C., Hovanessian, A. G., Franco, R. (1997) Adenosine deaminase binding to human CD26 is inhibited by HIV-1 envelope glycoprotein gp120 and viral particles. J. Immunol. 158, 3721-3729. (Pubitemid 127488727)
50. Robertson, S. J., Hasenkrug, K. J. (2006) The role of virus-induced regulatory T cells in immunopathology. Springer Semin. Immunopathol. 28, 51-62.
51. Zeiser, R., Negrin, R. S. (2008) Interleukin-2 receptor downstream events in regulatory T cells: implications for the choice of immunosuppressive drug therapy. Cell Cycle 7, 458-462.
52. Quezada, S. A., Peggs, K. S., Curran, M. A., Allison, J. P. (2006) CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells. J. Clin. Invest. 116, 1935-1945.
53. Korn, T., Oukka, M., Kuchroo, V., Bettelli, E. (2007) Th17 cells: effector T cells with inflammatory properties. Semin. Immunol. 19, 362-371. (Pubitemid 351274046)
54. Oukka, M. (2008) Th17 cells in immunity and autoimmunity. Ann. Rheum. Dis. 67 (Suppl. 3), iii26 -iii29.
55. Seder, R. A., Darrah, P. A., Roederer, M. (2008) T-cell quality in memory and protection: implications for vaccine design. Nat. Rev. Immunol. 8, 247-258.